PL2120958T3 - Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby - Google Patents

Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby

Info

Publication number
PL2120958T3
PL2120958T3 PL07868993T PL07868993T PL2120958T3 PL 2120958 T3 PL2120958 T3 PL 2120958T3 PL 07868993 T PL07868993 T PL 07868993T PL 07868993 T PL07868993 T PL 07868993T PL 2120958 T3 PL2120958 T3 PL 2120958T3
Authority
PL
Poland
Prior art keywords
associated methods
cancer activity
stat3 inhibitor
stat3
inhibitor
Prior art date
Application number
PL07868993T
Other languages
English (en)
Inventor
James Turkson
Andrew D Hamilton
Richard Jove
Said M Sebti
Original Assignee
Univ Central Florida Res Found Inc
Univ Yale
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Central Florida Res Found Inc, Univ Yale, Univ South Florida filed Critical Univ Central Florida Res Found Inc
Publication of PL2120958T3 publication Critical patent/PL2120958T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07868993T 2006-12-06 2007-12-05 Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby PL2120958T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86879406P 2006-12-06 2006-12-06
EP07868993.2A EP2120958B8 (en) 2006-12-06 2007-12-05 Stat3 inhibitor having anti-cancer activity and associated methods
PCT/US2007/086453 WO2008070697A2 (en) 2006-12-06 2007-12-05 Stat3 inhibitor having anti-cancer activity and associated methods

Publications (1)

Publication Number Publication Date
PL2120958T3 true PL2120958T3 (pl) 2013-10-31

Family

ID=39493046

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07868993T PL2120958T3 (pl) 2006-12-06 2007-12-05 Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby

Country Status (6)

Country Link
US (1) US8609639B2 (pl)
EP (1) EP2120958B8 (pl)
CA (1) CA2671121C (pl)
DK (1) DK2120958T3 (pl)
PL (1) PL2120958T3 (pl)
WO (1) WO2008070697A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2120958T3 (da) 2006-12-06 2013-07-01 Univ Central Florida Res Found Stat3-inhibitor med anticancer-aktivitet og associerede fremgangsmåder
CA2737360A1 (en) * 2008-09-17 2010-03-25 University Of Central Florida Research Foundation, Inc. Inhibitors of stat3
DE112013002944T5 (de) 2012-06-13 2015-02-19 Innotec, Corp. Flexibler Hohllichtleiter
WO2015120436A2 (en) 2014-02-10 2015-08-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 phosphorylation during graft-versus-host disease
WO2015164870A1 (en) 2014-04-25 2015-10-29 H. Lee Moffitt Cancer Center And Research Institute, Inc. Gamma-aa-peptide stat3/dna inhibitors and methods of use
US11786457B2 (en) 2015-01-30 2023-10-17 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2599393A1 (en) 2005-02-25 2006-08-31 The Regents Of The University Of Michigan Small molecule inhibitors of stat3 and the uses thereof
CA2649288C (en) * 2006-04-19 2015-11-24 Novartis Ag 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
DK2120958T3 (da) 2006-12-06 2013-07-01 Univ Central Florida Res Found Stat3-inhibitor med anticancer-aktivitet og associerede fremgangsmåder

Also Published As

Publication number Publication date
US20110124602A1 (en) 2011-05-26
EP2120958A2 (en) 2009-11-25
EP2120958B1 (en) 2013-03-20
US8609639B2 (en) 2013-12-17
DK2120958T3 (da) 2013-07-01
WO2008070697A2 (en) 2008-06-12
CA2671121C (en) 2016-06-07
EP2120958A4 (en) 2011-11-09
EP2120958B8 (en) 2013-05-15
WO2008070697A4 (en) 2009-01-22
CA2671121A1 (en) 2008-06-12
WO2008070697A3 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
IL284889A (en) Imidazotriazines and imidazopyrimidines as kinase inhibitors
EP2035005A4 (en) THERAPY BASED ON CYTOKINE INHIBITORS
EP2214669A4 (en) cytokine inhibitors
EP2200977A4 (en) F1F0-ATPASE INHIBITOR AND ASSOCIATED METHODS
PL2117521T3 (pl) Transdermalne systemy dostarczania zawierające bupiwakainę
ZA200810323B (en) Fkbp-l and uses thereof
ZA200901874B (en) Stat3/5 activation inhibitor
LT2064327T (lt) Dbait ir jų panaudojimas
ZA200709854B (en) 17ß-HSD1 and STS inhibitors
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
ZA200903906B (en) Carboranylporphyrins and uses thereof
EP2077262A4 (en) IMINOPYRIDINE DERIVATIVE AND USE THEREOF
PL2120958T3 (pl) Inhibitor stat3 posiadający właściwości przeciwnowotworowe i powiązane sposoby
EP2028971A4 (en) WORK AREA
IL199427A (en) Radiation-protective compounds and related methods
EP2020167A4 (en) GENERIC SYSTEMS AND METHODS FOR ANTI-ELECTROMAGNETIC SHIELDING
GB0622702D0 (en) Selective glycosidase inhibitors
GB0610059D0 (en) Uses and methods
GB0609094D0 (en) Steel set chair
GB0621665D0 (en) Blogmail and podmail
GB0606794D0 (en) Methods and uses
ZA200609603B (en) Shim
GB0604711D0 (en) Architrave Support And Architrave Relating Thereto
PH32006000458S1 (en) Buffet
GB0902072D0 (en) Calendar